FROG Insider: CFO Disposes of 16,445 Shares via 10b5-1
Rhea-AI Filing Summary
Eduard Grabscheid, Chief Financial Officer of JFrog Ltd. (FROG), reported insider sales executed under a Rule 10b5-1 trading plan. On 08/18/2025 the reporting person sold a total of 16,445 ordinary shares in two transactions: 15,654 shares at a weighted average price of $44.46 and 791 shares at $45. After these disposals, the filing shows beneficial ownership of 144,233 shares following the larger sale and 143,442 shares following the smaller sale. The Form 4 notes the 10b5-1 plan was adopted May 16, 2025, and the report was signed by a representative under power of attorney on 08/20/2025. The filing asserts the seller will provide transaction-level price and quantity details to the SEC or other requestors.
Positive
- Sales were executed under a documented Rule 10b5-1 trading plan, which indicates pre-planned dispositions rather than ad-hoc insider trading
- Filing discloses weighted-average sale price ($44.46 for the larger block) and commits to provide per-trade details on request, supporting transparency
- Form 4 identifies reporting person and officer role (CFO), meeting Section 16 disclosure requirements
Negative
- Insider holdings decreased by 16,445 shares (15,654 + 791), reducing the CFO's beneficial ownership to 143,442 shares after the reported transactions
- Form does not include per-trade breakdown in the filing itself; specific quantities at each price are available only upon request
Insights
TL;DR: CFO sold 16,445 shares under a 10b5-1 plan; proceeds determined by reported weighted-average prices.
The Form 4 documents routine insider sales by the CFO executed under a pre-established Rule 10b5-1 trading plan adopted May 16, 2025. The filing provides aggregate share counts and weighted-average prices ($44.46 and $45) and discloses remaining beneficial ownership after each reported disposal (144,233 and 143,442 shares). For investors, these are non-discretionary plan sales rather than ad-hoc dispositions, and the filer has committed to provide transaction-level breakdowns on request. No derivative or other compensatory transactions are reported.
TL;DR: Disclosure aligns with Section 16 reporting and documents use of a 10b5-1 plan; signature by POA is noted.
The filing complies with Section 16 format: it identifies the reporting person as an officer (CFO), specifies the 10b5-1 plan adoption date (May 16, 2025), and reports sales with post-transaction beneficial ownership. The Form 4 is signed by a power-of-attorney designee (Shanti Ariker) dated 08/20/2025, which is an accepted practice when authorized. The filing offers to supply per-trade quantities and prices to regulators or shareholders upon request, supporting transparency. There are no disclosures here of option exercises, grants, or unusual compensation-related derivatives.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 15,654 | $44.46 | $696K |
| Sale | Ordinary Shares | 791 | $45.00 | $36K |
Footnotes (2)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $43.99 to $44.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
FAQ
What insider transactions did JFrog (FROG) disclose for Eduard Grabscheid?
Were the sales by the FROG CFO part of a Rule 10b5-1 plan?
Who signed the Form 4 for the reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.
